ROCKET LAB CORP (RKLB) FY2026 Q2 Balance Sheet
As of 2026-06-30
Balance Sheet
As of 2026-06-30
Swipe to see the full flow
Chart details
ROCKET LAB CORP (RKLB) FY2026 Q2 Balance Sheet
Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.
- Assets
- 4,187,374,000 US dollars
- Current assets
- 2,895,759,000 US dollars
- Non-current assets
- 1,291,615,000 US dollars
- Liabilities
- 695,221,000 US dollars
- Current liabilities
- 528,196,000 US dollars
- Non-current liabilities
- 167,025,000 US dollars
- Equity
- 3,492,153,000 US dollars
- Cash and cash equivalents
- 2,129,485,000 US dollars
- Inventories
- 266,931,000 US dollars
- Marketable securities, current
- 172,700,000 US dollars
- Prepaids and other current assets
- 119,509,000 US dollars
- Accounts receivable, net
- 112,889,000 US dollars
- Contract assets
- 94,245,000 US dollars
- Property, plant and equipment, net
- 393,946,000 US dollars
- Intangible assets, net
- 320,415,000 US dollars
- Goodwill
- 299,072,000 US dollars
- Right-of-use assets - operating leases
- 113,690,000 US dollars
- Marketable securities, non-current
- 85,405,000 US dollars
- Other non-current assets
- 57,268,000 US dollars
- Right-of-use assets - finance leases
- 12,349,000 US dollars
- Restricted cash
- 8,413,000 US dollars
- Deferred income tax assets, net
- 1,057,000 US dollars
- Contract liabilities
- 351,193,000 US dollars
- Trade payables
- 74,512,000 US dollars
- Accrued expenses
- 44,206,000 US dollars
- Other current liabilities
- 29,167,000 US dollars
- Employee benefits payable
- 29,118,000 US dollars
- Non-current operating lease liabilities
- 104,378,000 US dollars
- Other non-current liabilities
- 23,188,000 US dollars
- Non-current finance lease liabilities
- 14,468,000 US dollars
- Convertible senior notes, net
- 13,129,000 US dollars
- Deferred income tax liabilities
- 10,146,000 US dollars
- Long-term borrowings, net
- 1,716,000 US dollars
- Additional paid-in capital
- 4,606,854,000 US dollars
- Common stock, $0.0001 par value; authorized shares: 2,500,000,000; issued shares: 639,131,688 and 589,525,802 at June 30, 2026 and December 31, 2025, respectively; outstanding shares: 598,180,438 and 543,574,552 at June 30, 2026 and December 31, 2025, respectively
- 60,000 US dollars
- Preferred stock, $0.0001 par value; authorized shares: 100,000,000; issued and outstanding shares: 40,951,250 and 45,951,250 at June 30, 2026 and December 31, 2025, respectively
- 4,000 US dollars
- Treasury stock, at cost; shares: 40,951,250 and 45,951,250 at June 30, 2026 and December 31, 2025, respectively
- 0 US dollars
- Accumulated deficit
- negative 1,106,190,000 US dollars
- Accumulated other comprehensive loss
- negative 8,575,000 US dollars
- Gross equity (calculated)
- 4,606,918,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.
Chart connections
- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
